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electromagnetic magnetic resonance fields may occur. Complete
inhibition of pacemaker output in pacemaker-dependent patients
and/or false triggering with tracking to the upper rate limit in
patients with reduced left ventricular function may be detrimental.
Therefore, we cannot support the approach of Martin and
co-workers—that is, to leave the pacemaker sensing function
activated. In contrast, we recommend deactivating the sensing
function in pacemaker-dependent patients by programming the
pacemaker device to an asynchronous mode, to ensure continuous
pacing, and to program the pacemaker device to a sensing-only
mode (0X0) or subthreshold pacing in nonpacemaker-dependent
patients to avoid MRI-related triggering.
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REPLY
We thank Dr. Sommer and colleagues for their interest in our
work (1). We agree that the magnet mode of the pacemaker is not
always maintained during magnetic resonance imaging (MRI). We
have in fact observed this phenomenon during our experience.
This phenomenon is related to the position of the pulse generator
relative to the isocenter of the magnetic field. However, this does
not alter our recommendations for imaging these patients.
Their statement regarding the possibility of an open reed switch
leading to false inhibition and/or false triggering is valid. However,
it was for this reason that pacemaker-dependent patients were
excluded from our study. We were also concerned about thermo-
genic damage at the lead-tissue interface with subsequent loss of
capture, which would also be detrimental in pacemaker-dependent
patients. Finally, we did not alter pacemaker sensing, because in
our experience over-sensing on the atrial channel occurs extremely
infrequently.
Pacemaker-dependent patients can likely undergo MRI as long
as sensing is disabled. However, the possibility of thermogenic
damage and loss of capture cannot be overstated.
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RESTORE—From
Deduction to Leap of Faith
In a recent study in JACC by the RESTORE Investigators, the
researchers equate postoperative elevation in left ventricular ejection
fraction (LVEF) (29.6% to 39.5%) and decrease in left ventricular
end-systolic index (LVESI) (80 ml to 56 ml) to improved LV
function. However, an increase in LVEF and a decrease in LVESI are
geometric necessities of the operation, which involves a concentric
shrinking of the infarcted anterior/septal myocardial area with a
purse-string stitch, and closure of the small residual defect with an
oval patch. They are predicated within the notion of the ventricular
reduction itself, assuming the remaining sarcomeres continue their
usual function. To say that ventricular function is improved, one
would need data to show that stroke volume or, secondarily, pulmo-
nary artery pressures or cardiac output improved. None of these data
were provided; indeed, one would expect stroke volume and cardiac
output not to change, and pulmonary artery pressures to fall based on
Laplace’s law.
The investigators make a good case in their discussion that they
have helped their patients based on historical series involving
individual components of the operation in subjects with dilated
hearts (coronary artery bypass graft, ventricular aneurysmectomy,
mitral repair). But the leap from what is essentially a deductive
tautology (A  A) to their empiric finding of improved clinical
symptoms requires hemodynamic data for inductive reasoning
about cause and effect (1).
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The RESTORE registry was accumulated to confirm the extensive
experience of Dor and his colleagues, which dates back about 20
years. The primary reason for presenting these data was to
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demonstrate that volume reduction and shape changes are valuable
components in the treatment of congestive heart failure following
infarction. Ejection fraction improved, volume was reduced, and
clinical status improved by New York Heart Association (NYHA)
functional classification status. Moreover, five-year survival was
very gratifying, especially when compared to conventional therapy.
The effects of ventricular restoration have been studied and
referenced in our report (1). These include improvement of systolic
and diastolic function, confirmed by the centerline method and
pressure-volume loop studies. The operation’s primary physiolog-
ical impact is on the remote noninfarcted myocardium and has
been well described.
Our study did not report hemodynamics because we believe that
little can be extrapolated from such data. It is well known that
heart failure progresses independently of hemodynamic status and
is directly related to ventricular size and shape changes (2,3).
Indeed, patients with markedly dilated hearts and advanced heart
failure often have normal cardiac output and pulmonary pressures
at rest. Our reporting is, therefore, consistent with the majority of
clinical trials of heart failure, few of which assert that acute resting
hemodynamic changes are of functional or prognostic significance.
Hemodynamics, however, may be of value during exercise.
Consequently, conversion of 67% in NYHA functional class III/IV
category to 85% in class I/II seems an effective functional coun-
terpart. In the meanwhile, the recently documented neuro-
hormonal consequences of ventricular restoration are very perti-
nent to the reviewer’s comments regarding “cause and effect” (4).
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Cardiac Magnetic
Resonance-Directed Intervention
in Non–ST-Segment Elevation
Acute Coronary Syndrome
I read with great interest the study by Plein et al. (1) on the use of
cardiac magnetic resonance (CMR) imaging to determine the
presence of significant coronary stenosis in patients with non–ST-
segment elevation acute coronary syndromes (NSTE-ACS). The
investigators showed an impressive sensitivity (96%) and specificity
(83%) to predict significant coronary stenosis using combined
myocardial function, perfusion, viability (employing late enhance-
ment), and coronary anatomy. They also pointed out that the
diagnostic yield of combining only perfusion, wall motion, and late
enhancement was similar without the addition of CMR angiog-
raphy, representing a significant reduction in scanning time.
The advent of evidence-based international guidelines that all
patients with NSTE-ACS should undergo early (72 h) revascu-
larization (2,3) has created both an enormous burden on world-
wide health care systems and long inpatient waiting times for
intervention (4). A more precise risk-stratification of those patients
with a diagnosis of NSTE-myocardial infarction, such as that
advocated by the Plein et al. (1) study, would prevent exposing
patients to unnecessary risk and markedly alleviate the extra burden
on health care systems. This is particularly relevant to this study as
only 53% of subjects had a positive troponin level and thereby
fulfilled the definition of NSTE-ACS and evidence-based criteria
for early intervention.
The difficulty of accurate risk-stratification highlights the im-
portance of the study by Plein et al. (1), but the real strength of
CMR lies in not only detecting coronary artery stenoses, but in
directing interventional therapy. Although 56 of the 68 patients
studied were found to have coronary artery disease, a more
profound question is whether the stenotic vessel supplied a
territory that was viable or ischemic, as these are the stenoses that,
when treated, result in beneficial ventricular remodeling, progno-
sis, or reduction in symptoms (5). This information is inherent in
the CMR technique and therefore readily already available to the
investigators. Further analysis of the data would determine how
appropriate the intervention was, and allow the potential cost
benefit of a single CMR scan to be calculated.
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